Then & Now: 20 Years and Still Going Strong
Then & Now: 20 Years and Still Going Strong
OCRF Board Member, Robin Zarel, Celebrates 20 Years as an Ovarian Cancer Survivor.
News
Supreme Court to Consider Two Birth Control Lawsuits
Supreme Court to Consider Two Birth Control Lawsuits
The Supreme Court recently announced that it will hear two cases involving insurance coverage for birth control. The Alliance weighed in on one of these cases, arguing that oral contraceptives … Continued
Scientists Ask: Does Ovarian Cancer Have a Smell?
Scientists Ask: Does Ovarian Cancer Have a Smell?
George Preti, who works at the Monell Chemical Senses Center as an organic chemist, and an interdisciplinary team that includes physicists and veterinarians at the University of Pennsylvania are using … Continued
Partner Member Profile: Ovacome
Partner Member Profile: Ovacome
In 1999, Frieda Hooper was diagnosed with ovarian cancer. Frustrated with the lack of educational and supportive resources available, Hooper formed a support group for women with ovarian cancer in … Continued
OCRF Research Shows that Combining Targeted Agents is Effec...
OCRF Research Shows that Combining Targeted Agents is Effective Against Ovarian Cancer
New research funded in part by OCRF has shown that combining microRNA and siRNAs may be an effective new approach to developing better targeted therapies for ovarian cancer. The research … Continued
Use of a Chemoresponse Assay Improves Clinical Outcomes
Use of a Chemoresponse Assay Improves Clinical Outcomes
Research published in the November 2013 issue of Gynecologic Oncology reports that the use of the chemoresponse assay ChemoFx can lead to improved clinical outcomes for women undergoing treatment for … Continued
Quality of life: Primary Debulking Surgery versus Neo-adjuv...
Quality of life: Primary Debulking Surgery versus Neo-adjuvant Chemotherapy
An international group of researchers examined quality of life factors for ovarian cancer patients enrolled in a large European clincial trial (EORTC 55971). They compared the quality of life patients … Continued
Partner Member Profile: Sherie Hildreth Ovarian Cancer Foun...
Partner Member Profile: Sherie Hildreth Ovarian Cancer Foundation
In 2004, Sherie Hildreth was diagnosed with ovarian cancer. If the disease alone wasn’t frustrating enough, there was a lack of resources and what seemed like no other women to … Continued
New Study find Hot Ovarian Cancer Cells are Easier to Kill
New Study find Hot Ovarian Cancer Cells are Easier to Kill
Oregon State University researchers have found that using nanotechnology with heat and cytotoxic drugs can kill up to 95% of ovarian cancer cells. While there is still additional research that … Continued
New Clue in BRCA1 and BRCA2 Mutations
New Clue in BRCA1 and BRCA2 Mutations
A new study released in Lancet Oncology showed that abnormal levels of female hormones in the bloodstream may be why women with BRCA1 or BRCA2 mutations are at a higher risk … Continued
DNA "Tags" Could Guide Treatment
DNA "Tags" Could Guide Treatment
A new study conducted by Cancer Research UK has identified chemical “tags” on DNA in patients’ tumors that could help doctors decide the type of chemotherapy women with advanced ovarian … Continued
New Discovery of Inflammation Process of Some Ovarian Cance...
New Discovery of Inflammation Process of Some Ovarian Cancer Tumors Could Help Expand Treatment
A study led by Dr. Andrew Stephens from the Prince Henry’s Institute has discovered a process that is associated with inflammation in cancers. This discovery could lead to expanded treatment … Continued